|
Jan 5
|
Omega (OMGA) Up 95% on Obesity Drug Deal With Novo Nordisk
|
|
Jan 5
|
Lilly (LLY) Starts Website to Help Access Tirzepatide Drugs
|
|
Jan 5
|
Novo Nordisk (NVO) Up on $1.1B Research Deals With 2 Biotechs
|
|
Jan 5
|
Pharma Stock Roundup: LLY's New Digital Pharmacy, NVO & ABBV's Fresh R&D Deals
|
|
Jan 5
|
Dow Jones Futures Fall Amid Jobs Report As Fed Doubts Grow; Spot Bitcoin ETFs Loom
|
|
Jan 2
|
YEARENDER-Weight-loss drugs: Who, and what, are they good for?
|
|
Jan 2
|
EXPLAINER-What other health conditions might weight-loss drugs treat?
|
|
Jan 1
|
Prediction: These 3 Stocks Will Soar in 2024
|
|
Dec 30
|
Ozempic drugmaker to open AI research hub in King’s Cross
|
|
Dec 30
|
14 Money Making Stocks To Invest In
|
|
Dec 29
|
Neurological and obesity drugs will be prevalent in 2024
|
|
Dec 28
|
The Zacks Analyst Blog Highlights Novo Nordisk, Walmart, Advanced Micro Devices, Caterpillar and Union Pacific
|
|
Dec 28
|
Interested in the Weight-Loss Market? Here's 1 Stock to Buy Hand Over Fist in 2024, and 1 to Avoid Like the Plague.
|
|
Dec 28
|
Novo Nordisk (NVO) Rose on Increased Demand
|
|
Dec 27
|
Top Analyst Reports for Novo Nordisk, Walmart & AMD
|
|
Dec 27
|
TipRanks’ ‘Perfect 10’ List: These 3 Top-Scoring Stocks Are Poised to Perform in 2024
|
|
Dec 27
|
Healthcare Stocks Had a Terrible 2023. Things Are Looking Up.
|
|
Dec 26
|
Sarepta (SRPT) Seeks Label Expansion for DMD Gene Therapy
|
|
Dec 23
|
Will Novo Nordisk Be Worth More Than Meta Platforms by 2030?
|
|
Dec 22
|
FDA warns Americans about fake Ozempic
|